UPCOMING CONFERENCE
AD/PD™ 2027
March 16-20, 2027 | Barcelona, Spain
The AD/PD™ Conference has become the main event of the year in the field of neurodegenerative diseases, attracting leading medical and scientific professionals from around the world. AD/PD™ is an annual meeting, with a continuing focus on the ADVANCES IN SCIENCE & THERAPY of Alzheimer’s and Parkinson’s Diseases and related neurological disorders.
Join AD/PD™ Education on UNLOK
Become part of the world’s leading network dedicated to advancing the science and treatment of neurodegenerative diseases.
Submit your Late-Breaking Abstract for AD/PD™ 2027
Late-Breaking abstract submission is open for Barcelona 2027. Don't miss the November 18 deadline, share your research today!
Startup Hub
The place where innovative startups in Alzheimer’s & Parkinson’s treatment presenting the latest achievements.
News & Highlights
NEW: Session Recordings from AD/PD™ 2026
Watch the full library of sessions available exclusively on the AD/PD™ on UNLOK Education Portal.
AD/PD™ 2027 - Call for Abstracts
Late-Breaking abstract submission for AD/PD™ 2027 is open! Join the scientific program by the November 18 .
New AD/PD™ Podcast Series
Listen to the first episode of AD/PD™ Neuro Talks: Early Alzheimer’s in Focus featuring Dr. Soeren Mattke.
Register Early and Save for AD/PD™ 2027
AD/PD™ 2027 is the place to discover the latest advances in neurodegenerative disease research, from basic science to clinical practice. Register by 9 December to save up to €150.
Alzheimer’s Research Evidence to Asian Practice
Expert-led session on applying the latest AD research to real-world clinical practice in Asia.
Exercise & Lifestyle
Taking Steps to Ward Off Tangles
According to a paper in Nature Medicine on November 3, treading upwards of 7,500 steps per day may slow progression of Alzheimer’s disease
Cognition Bump from Better Lifestyle: Due to Healthy Heart, Sound Sleep?
Structured lifestyle makeover in older adults improves scores on memory and thinking tests
Association between Physical Activity and Lifestyle, Life Expectancy, and Quality of Life in Patients with AD
Physical activity has a significant effect on QOL
Slew of Studies Tie Health and Lifestyle Factors to Parkinson’s
Five new studies reveal modifiable factors shaping Parkinson’s risk, pointing to new opportunities for prevention.
Can Exercise Protect People Whose Plasma Tau Is Up?
Staying active has many health benefits, including, perhaps, to help preserve memory. Alas, is this true in some more than others?
Latest Breakthroughs & Updates
AlzForum Conference Coverage
Check out 26+ articles covering some of the breakthroughs presented at AD/PD™ 2026 in Copenhagen
Science
Access AD/PD™ 2026 sessions online
Couldn't make it to Copenhagen or looking to rewatch sessions? The Gold Track registration upgrade gives you extended access to view the sessions online.
Conference
Access AD/PD™ Education on UNLOK
Register your free account today to access AD/PD™ Conference recordings, free eLearning courses, live webinars and more.
Education
- AD/PD™ Neuro Talks: Early Alzheimer’s in Focus – Our brand-new podcast series is now live!
- AD/PD™ 2027 Abstract Submission – Late-Breaking Submissions are open until November 18
About AD/PD™
HISTORY
The AD/PD™ Conference began its journey in 1985 in Eilat, Israel, as a focused gathering of around 300 passionate scientists and clinicians dedicated to Alzheimer’s and Parkinson’s diseases. Over the past four decades, it has steadily grown alongside the field itself, reflecting major scientific and clinical advances. Today, AD/PD™ brings together nearly 6,000 participants each year, making it one of the world’s leading international meetings in neurodegenerative disease research.
MISSION
At the heart of AD/PD™ is the recognition of the strong biological and clinical overlap between Alzheimer’s and Parkinson’s diseases, a concept that continues to shape the conference’s identity. AD/PD™ is uniquely committed to bridging basic science and high-level clinical research, fostering meaningful dialogue between laboratory researchers and clinicians. Guided by the motto “Advances in Science and Therapy,” the conference strives for a better future for all those affected by neurodegenerative diseases.
Photo Gallery
Press Releases
World-Leading Speakers to Take the Stage at AD/PD™
AD/PD™ brings together an exceptional faculty of internationally renowned scientists and clinicians at the forefront of Alzheimer’s, Parkinson’s, and related neurodegenerative disorders. From groundbreaking basic researchers to influential clinical leaders, the conference offers a rare opportunity to hear directly from those shaping the future of the field.
A Comprehensive Scientific Program at AD/PD™
The AD/PD™ program delivers a carefully curated mix of basic science, translational research, and high-level clinical sessions. With symposia, workshops, and plenary lectures, the conference is designed to encourage dialogue across disciplines and disease areas.
Breakthrough Research Highlights Presented at AD/PD™
The previous AD/PD™ meeting showcased cutting-edge research spanning novel disease mechanisms, biomarkers, and therapeutic strategies. Hundreds of oral presentations and posters highlighted the rapid progress being made across Alzheimer’s, Parkinson’s, and overlapping neurodegenerative conditions.